Research Paper Volume 12, Issue 18 pp 18363—18383
A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer
Figure 6. The nomogram to predict risk of cancer recurrence in GSE39582. (A) The nomogram for predicting proportion of patients with disease-free survival. (B) The calibration plots for predicting recurrence at 3 years. Nomogram-predicted probability of recurrence is plotted on the x-axis; actual recurrence is plotted on the y-axis. The solid line represents our nomogram and the vertical bars represent 95 percent confidence intervals. (C) ROC curve based on the nomogram for recurrence probability.